Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Colorectal Neoplasms 8Venous Thromboembolism 4Polycythemia Vera 3Prostatic Neoplasms 2Neoplasms 2Myeloproliferative Disorders 2Fallopian Tube Neoplasms 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Breast Neoplasms 2Thrombocythemia, Essential 1Testicular Neoplasms 1Smoking Cessation 1Sarcoma 1Primary Myelofibrosis 1Ovarian Neoplasms 1Ovarian Cancer Prevention 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neoplasms, Germ Cell and Embryonal 1Multiple Myeloma 1Motor Activity 1Lung Neoplasms 1Liver Cirrhosis 1Leukemia, Hairy Cell 1Inflammation 1Hemorrhage 1Hematoma 1Fibrosis 1Endometrial Neoplasms 1Colorectal Neoplasia 1

Interventions

Fulvestrant 125Trastuzumab 114Paclitaxel 113Letrozole 108pembrolizumab 79pertuzumab 75palbociclib 75Capecitabine 72Anastrozole 72Cyclophosphamide 70Carboplatin 67abemaciclib 64exemestane 63Tamoxifen 63ribociclib 60trastuzumab deruxtecan 57Surveys and Questionnaires 51Specimen Handling 50Radiotherapy 49Docetaxel 49Magnetic Resonance Spectroscopy 48Blood Specimen Collection 40olaparib 39Standard of Care 36Biopsy 33sacituzumab govitecan 31130-nm albumin-bound paclitaxel 31Doxorubicin 30Exercise 29eribulin 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × Aspirin × 1 year × Clear all
NCT05557877 2026-05-12

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Mayo Clinic

Phase 2 Recruiting
60 enrolled
Breast

Breast Neoplasms

NCT04188119 2025-12-08

IMpALA

The Christie NHS Foundation Trust

Phase 2 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡